Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a ...
4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...
In clinics across Europe, older adults tried a new way to sharpen fading sight. It involved a wafer-thin chip and smart glasses. What the trial shows ...
Age-related macular degeneration (AMD) is a common eye condition in older adults that can affect central vision. Geographic atrophy is an advanced form of AMD that causes permanent vision changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback